Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 19, 2009
Quantitative structure activity relationship studies of piperazinyl phenylalanine derivatives as VLA-4/VCAM-1 inhibitorsDinesh Bhargava, C Karthikeyan, N S H N Moorthy, et al.Expert Opinion on Drug Delivery|July 7, 2015
Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performancePremjeet Singh Sandhu, Sarwar Beg, Farhad Mehta, et al.Current Drug Targets|February 24, 2017
Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and ObesityNeelesh Maheshwari, Chandrabose Karthikeyan, Piyush Trivedi, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2004
QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptorsS Balaji, C Karthikeyan, N S Hari Narayana Moorthy, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|June 4, 2011
Synthesis, in silico metabolic and toxicity prediction of some novel imidazolinones derivatives as potent anticonvulsant agentsN S Hari Narayana Moorthy, Vipin Saxena, C Karthikeyan, et al.Mini Reviews in Medicinal Chemistry|May 25, 2013
6H-Indolo[2,3-b]quinoxalines: DNA and protein interacting scaffold for pharmacological activitiesN S Hari Narayana Moorthy, E Manivannan, C Karthikeyan, et al.Chemistry & Biodiversity|September 6, 2021
Unravelling the Selectivity of 6,7-Dimethyl Quinoxaline Analogs for Kinase Inhibition: An Insight towards the Development of Alzheimer's TherapeuticsArvind Kumar Jain, Arindam Gupta, C Karthikeyan, et al.Chemistry & Biodiversity|August 19, 2022
Substituent Orchestration in Dimethylquinoxaline Derivatives: A Tool for Fishing Out Appropriate CDK5 Inhibitors as Potential Therapeutics for Alzheimer'sArvind Kumar Jain, Arindam Gupta, C Karthikeyan, et al.Oncotarget|April 11, 2017
Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivoMohadeseh Hasanpourghadi, Ashok Kumar Pandurangan, Chandrabose Karthikeyan, et al.Chemical & Pharmaceutical Bulletin|November 2, 2006
Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptorsPalanivelu Manoj Kumar, Chandrabose Karthikeyan, Narayana Subbiah Hari Narayana Moorthy, et al.Pageof 7